ASTH (ASTH) Misses Q4 EPS by 25c ; Offers Guidance

ASTH (NASDAQ: ASTH) reported Q4 EPS of ($0.15), $0.25 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $665.2 million versus the consensus estimate of $602.68 million.

GUIDANCE:

ASTH sees FY2025 revenue of $2.5-2.7 billion, versus the consensus of $2.61 billion.

For earnings history and earnings-related data on ASTH (ASTH) click here.

You May Also Be Interested In

• Astrana Health names two executives to expand leadership team
• Lode Gold plans $7M private placement with Coast Capital follow-on
• Syntholene Energy plans $1.5M private placement at $0.45 per unit